BRUCOX MYO

Dual Action Precision. Complete Musculoskeletal Control.

BRUCOX MYO is an advanced combination therapy crafted to deliver comprehensive relief in painful musculoskeletal conditions.

It unites Etoricoxib 60 mg, a selective COX-2 inhibitor known for precise anti-inflammatory action, with Tolperisone 150 mg, a centrally acting muscle relaxant that effectively reduces muscle spasm without excessive sedation.

Advanced Dual Composition:

• Etoricoxib – 60 mg
• Tolperisone – 150 mg

Therapeutic Advantages:

• Potent control of inflammation and pain
• Effective relief from muscle spasm and stiffness
• Improved flexibility and functional mobility
• Enhanced patient comfort with better tolerability
• Once-daily convenience for consistent therapeutic performance

Ideal for acute back pain, cervical and lumbar spondylosis, sports injuries, and painful spasm-related disorders, BRUCOX MYO is designed to restore movement with confidence.

Manufactured with pharmaceutical precision and guided by clinical excellence, BRUCOX MYO stands as a refined solution in modern pain and spasm management.

BRUCOX MYO — Relieve Pain. Relax Muscles. Restore Life.